Amy Abernethy — SPARQNOW

At-a-Glance

Cofounder of Highlander Health, established in April 2024, which includes a public interest platform and an investment arm for growth-stage health care companies.
Previously served as principal deputy commissioner at the FDA from 2019-2021.
A hematologist/oncologist and palliative medicine physician.
Author of over 500 publications.
Serves on the boards of public companies like athenahealth and CareDx, and private firms including insitro and Georgiamune.
Joined the Duke University Board of Trustees.

Biography

Amy Abernethy is the cofounder of Highlander Health, an organization she established in April 2024 with Brad Hirsch. Highlander Health aims to advance personalized patient care through two main entities: Highlander Health Institute, a public interest platform providing philanthropic grants for evidence generation solutions, and Highlander Health Partners, which invests capital and counsel in growth-stage health care companies.